CIK: 0001274403 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $299,110 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BEAM | BEAM THERAPEUTICS INC. | 4,540,132 | $77,228 | 25.8% | $24.56 | -29.1% | COM | 07373V105 |
| VIR | VIR BIOTECHNOLOGY INC. | 12,916,663 | $65,100 | 21.8% | $5.36 | 0.0% | COM | 92764N102 |
| MAZE | MAZE THERAPEUTICS INC. | 4,120,053 | $50,594 | 16.9% | $12.04 | -13.6% | COM | 578784100 |
| RAPP | RAPPORT THERAPEUTICS INC. | 3,728,738 | $42,433 | 14.2% | $23.15 | -54.2% | COM | 75383L102 |
| — | VERVE THERAPEUTICS INC. | 2,008,809 | $22,559 | 7.5% | $36.87 | — | COM | 92539P101 |
| LYEL | LYELL IMMUNOPHARMA INC. | 1,820,634 | $16,113 | 5.4% | $9.11 | 0.0% | COM NEW | 55083R203 |
| ERAS | ERASCA INC. | 11,055,554 | $14,096 | 4.7% | $17.12 | -92.2% | COM | 29479A108 |
| GOSS | GOSSAMER BIO INC. | 8,055,916 | $9,909 | 3.3% | $1.15 | -5.4% | COM | 38341P102 |
| QTTB | Q32 BIO INC. | 320,482 | $478 | 0.2% | $13.78 | -87.6% | COM | 746964105 |
| — | UNITY BIOTECHNOLOGY INC. | 1,004,817 | $386 | 0.1% | $0.40 | — | COM NEW | 91381U200 |
| CERO | CERO THERAPEUTICS HOLDINGS INC. | 22,389 | $216 | 0.1% | $12.44 | 0.0% | COM | 71902K402 |